Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,555 | 397 | 96.3% |
| Education | $286.33 | 7 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $952.01 | 51 | $0 (2024) |
| GlaxoSmithKline, LLC. | $906.41 | 56 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $598.66 | 29 | $0 (2024) |
| Insmed, Inc. | $547.93 | 22 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $480.63 | 29 | $0 (2024) |
| Mylan Specialty L.P. | $468.10 | 21 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $403.30 | 30 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $388.22 | 19 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $366.91 | 16 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $313.87 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,465 | 122 | AstraZeneca Pharmaceuticals LP ($372.99) |
| 2023 | $1,494 | 76 | GlaxoSmithKline, LLC. ($219.85) |
| 2022 | $1,830 | 94 | AstraZeneca Pharmaceuticals LP ($221.26) |
| 2021 | $1,954 | 111 | GlaxoSmithKline, LLC. ($219.37) |
| 2019 | $99.00 | 1 | Insmed, Inc. ($99.00) |
All Payment Transactions
404 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Cardiology | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/11/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $99.95 | General |
| Category: Immunology | ||||||
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.20 | General |
| Category: Immunology | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: Cardiology | ||||||
| 11/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Immunology | ||||||
| 11/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Pulmonology | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 963 | 1,210 | $206,628 | $54,072 |
| 2022 | 12 | 946 | 1,257 | $211,421 | $55,458 |
| 2021 | 11 | 1,092 | 1,386 | $227,323 | $57,931 |
| 2020 | 14 | 1,056 | 1,296 | $196,704 | $47,294 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 239 | 375 | $69,521 | $19,109 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 152 | 223 | $60,879 | $17,761 | 29.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 118 | 119 | $16,541 | $3,631 | 21.9% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 117 | 118 | $16,048 | $3,501 | 21.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $12,660 | $3,182 | 25.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 134 | 142 | $13,064 | $2,175 | 16.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 32 | 32 | $8,800 | $1,923 | 21.8% |
| 71045 | X-ray of chest, 1 view | Office | 2023 | 67 | 80 | $4,160 | $1,187 | 28.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 26 | 29 | $1,653 | $893.75 | 54.1% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 17 | 17 | $1,547 | $325.80 | 21.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 23 | $1,403 | $196.78 | 14.0% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 15 | 22 | $352.00 | $187.90 | 53.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 236 | 406 | $75,110 | $20,455 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 157 | 251 | $68,523 | $19,477 | 28.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 110 | 110 | $15,290 | $3,523 | 23.0% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 110 | 110 | $14,960 | $3,335 | 22.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 34 | 34 | $9,350 | $2,185 | 23.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 130 | 133 | $12,236 | $2,009 | 16.4% |
| 71045 | X-ray of chest, 1 view | Office | 2022 | 86 | 109 | $5,668 | $1,611 | 28.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $4,642 | $1,228 | 26.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 17 | 19 | $1,083 | $645.17 | 59.6% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 29 | 30 | $2,730 | $603.67 | 22.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 13 | 25 | $1,525 | $220.25 | 14.4% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 13 | 19 | $304.00 | $165.98 | 54.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 267 | 462 | $85,470 | $23,155 | 27.1% |
About Stacey Basquin, PAC
Stacey Basquin, PAC is a Physician Assistant healthcare provider based in Statesboro, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1760549919.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stacey Basquin, PAC has received a total of $7,841 in payments from pharmaceutical and medical device companies, with $2,465 received in 2024. These payments were reported across 404 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($7,555).
As a Medicare-enrolled provider, Basquin has provided services to 4,057 Medicare beneficiaries, totaling 5,149 services with total Medicare billing of $214,755. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Statesboro, GA
- Active Since 01/03/2007
- Last Updated 09/17/2020
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1760549919
Products in Payments
- Arikayce (Drug) $547.93
- DUPIXENT (Biological) $519.53
- TRELEGY ELLIPTA (Drug) $488.64
- OPSUMIT (Drug) $345.70
- NUCALA (Biological) $344.80
- XYWAV (Drug) $329.69
- FASENRA (Biological) $322.68
- GLASSIA (Biological) $313.87
- Prolastin-C Liquid (Biological) $309.47
- WAKIX (Drug) $304.44
- Adempas (Drug) $303.07
- UPTRAVI (Drug) $283.71
- STIOLTO RESPIMAT (Drug) $254.90
- Yupelri (Drug) $243.67
- OFEV (Drug) $225.73
- YUPELRI (Drug) $224.43
- Sunosi (Drug) $214.40
- BREZTRI (Drug) $177.63
- AIRSUPRA (Drug) $176.40
- TYVASO (Drug) $171.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Statesboro
Karri Ray, Pa-C, PA-C
Physician Assistant — Payments: $5,931
Toni Herring, Pa-C, PA-C
Physician Assistant — Payments: $3,548
Olivia Neeley, Pa-C, PA-C
Physician Assistant — Payments: $3,212
Autumn Venturelli, Pa, PA
Physician Assistant — Payments: $3,042
Mrs. Jennifer Williamson, Pa-C, PA-C
Physician Assistant — Payments: $2,594
Jaimi Patel, Pa-C, PA-C
Physician Assistant — Payments: $2,386